Target intelligence / Profile preview

Peroxiredoxin 2 pseudogene 1 (PRDX2P1)

Target
PRDX2P1
Molecular classification
Pseudogene, Non-coding RNA (in some contexts)
01

Overview

Peroxiredoxin 2 pseudogene 1 (PRDX2P1) is a genomic locus classified as a pseudogene; it comprises DNA that resembles the peroxiredoxin 2 gene but contains disabling mutations and generally does not encode a functional protein. Pseudogenes can be processed or non-processed depending on their origin; processed pseudogenes arise by retrotransposition and typically lack introns and upstream regulatory sequences, whereas non-processed pseudogenes result from gene duplication and can retain introns. While historically considered "genomic fossils," recent research indicates some pseudogenes can impact cell physiology by producing non-coding RNAs involved in regulatory functions such as miRNA decoy activity or chromatin remodeling. However, there is no evidence that PRDX2P1 plays any such role specifically, nor is it considered a drug target or biomarker in disease contexts. If a canonical therapeutic target is required, consider the parental gene, **Peroxiredoxin 2 (PRDX2)**, instead; PRDX2 is a functional enzyme involved in antioxidant defense and has potential disease relevance.

02

Mechanism of action

Not applicable as there are no drugs targeting this pseudogene

03

Biological functions

Potentially involved in gene regulation, such as miRNA sponging or generating non-coding RNAs
04

Disease associations

None specific to PRDX2P1General: Some pseudogenes may play roles in cancer and other diseases via regulatory RNAs, but no direct evidence for PRDX2P1
05

Safety considerations

Not applicable because this locus is nonfunctional as a protein and is not targeted therapeutically

Beyond the preview

Go deeper on Peroxiredoxin 2 pseudogene 1 (PRDX2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxiredoxin 2 pseudogene 1 (PRDX2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call